XML 12 R5.htm IDEA: XBRL DOCUMENT v3.24.3
STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Subscription Receivable [Member]
Accumulated Deficit [Member]
Treasury Stock, Common [Member]
Beginning Balance at Dec. 31, 2022 $ 40,033 $ 4 $ 203,482   $ (163,453)  
Beginning Balance (shares) at Dec. 31, 2022   41,199,197       105,144
Stock-based compensation 1,094   1,094      
Issuance of common stock and pre-funded warrants, for the purchase of common stock, net of issuance costs 30,301   30,301      
Issuance of common stock and pre-funded warrants, for the purchase of common stock, net of issuance costs, Shares   750,000        
Exercise of stock options 7   7      
Exercise of stock options (shares)   8,000        
Net Income (Loss) (6,589)       (6,589)  
Ending Balance at Mar. 31, 2023 64,846 $ 4 234,884   (170,042)  
Ending Balance (shares) at Mar. 31, 2023   41,957,197       105,144
Beginning Balance at Dec. 31, 2022 40,033 $ 4 203,482   (163,453)  
Beginning Balance (shares) at Dec. 31, 2022   41,199,197       105,144
Net Income (Loss) (42,381)          
Ending Balance at Sep. 30, 2023 42,303 $ 4 248,133   (205,834)  
Ending Balance (shares) at Sep. 30, 2023   42,169,697       105,144
Beginning Balance at Mar. 31, 2023 64,846 $ 4 234,884   (170,042)  
Beginning Balance (shares) at Mar. 31, 2023   41,957,197       105,144
Stock-based compensation 1,544   1,544      
Net Income (Loss) (10,990)       (10,990)  
Ending Balance at Jun. 30, 2023 55,400 $ 4 236,428   (181,032)  
Ending Balance (shares) at Jun. 30, 2023   41,957,197       105,144
Stock-based compensation 9,663   9,663      
Common stock warrants issued with debt 2,041   2,041      
Vesting of restricted stock awards (in shares)   212,500        
Net Income (Loss) (24,802)       (24,802)  
Ending Balance at Sep. 30, 2023 42,303 $ 4 248,133   (205,834)  
Ending Balance (shares) at Sep. 30, 2023   42,169,697       105,144
Beginning Balance at Dec. 31, 2023 19,763 $ 4 250,207   (230,448)  
Beginning Balance (shares) at Dec. 31, 2023   42,518,697       105,144
Stock-based compensation 2,072   2,072      
Exercise of stock options 4   8 $ (4)    
Exercise of stock options (shares)   6,500        
Net Income (Loss) (20,331)       (20,331)  
Ending Balance at Mar. 31, 2024 1,508 $ 4 252,287 (4) (250,779)  
Ending Balance (shares) at Mar. 31, 2024   42,525,197       105,144
Beginning Balance at Dec. 31, 2023 $ 19,763 $ 4 250,207   (230,448)  
Beginning Balance (shares) at Dec. 31, 2023   42,518,697       105,144
Exercise of stock options (shares) 42,500          
Net Income (Loss) $ (60,377)          
Ending Balance at Sep. 30, 2024 $ (34,051) $ 5 256,769   (290,825)  
Ending Balance (shares) at Sep. 30, 2024 2,583,242 45,705,939       105,144
Beginning Balance at Mar. 31, 2024 $ 1,508 $ 4 252,287 (4) (250,779)  
Beginning Balance (shares) at Mar. 31, 2024   42,525,197       105,144
Stock-based compensation 2,228   2,228      
Exercise of stock options 150   146 $ 4    
Exercise of stock options (shares)   36,000        
Net Income (Loss) (17,186)       (17,186)  
Ending Balance at Jun. 30, 2024 (13,300) $ 4 254,661   (267,965)  
Ending Balance (shares) at Jun. 30, 2024   42,561,197       105,144
Stock-based compensation 2,108   2,108      
Vesting of restricted stock awards (in shares)   561,500        
Exercise of stock options 1 $ 1        
Exercise of stock options (shares)   2,583,242        
Net Income (Loss) (22,860)       (22,860)  
Ending Balance at Sep. 30, 2024 $ (34,051) $ 5 $ 256,769   $ (290,825)  
Ending Balance (shares) at Sep. 30, 2024 2,583,242 45,705,939       105,144